Login / Signup

Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.

Mabel Sarpong-DuahMichael FrimpongMarcus BeissnerMalkin SaarKen LaingFrancisca SarpongAloysius Dzigbordi LogloKabiru Mohammed AbassMargaret FrempongFred Stephen SarfoGisela BretzelMark Wansbrough-JonesRichard Odame Phillips
Published in: PLoS neglected tropical diseases (2017)
Current antibiotic therapy for BU is highly successful in most patients but it may be possible to abbreviate treatment to 4 weeks in patients with a low initial bacterial load. On the other hand persistent infection contributes to slow healing in patients with a high bacterial load at baseline, some of whom may need antibiotic treatment extended beyond 8 weeks. Bacterial load was estimated from a single sample taken at baseline. A better estimate could be made by taking multiple samples or biopsies but this was not ethically acceptable.
Keyphrases
  • end stage renal disease
  • mycobacterium tuberculosis
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • combination therapy
  • prognostic factors
  • gestational age
  • patient reported outcomes